FDA approves new pancreatic cancer drug that could extend patients' lives

The Food and Drug Administration on Wednesday approved [ a groundbreaking new drug ][17] for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonr...